BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8523074)

  • 1. Prognostic implications of chromosome 17p deletions in human medulloblastomas.
    Batra SK; McLendon RE; Koo JS; Castelino-Prabhu S; Fuchs HE; Krischer JP; Friedman HS; Bigner DD; Bigner SH
    J Neurooncol; 1995; 24(1):39-45. PubMed ID: 8523074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial.
    Clifford SC; Lannering B; Schwalbe EC; Hicks D; O'Toole K; Nicholson SL; Goschzik T; Zur Mühlen A; Figarella-Branger D; Doz F; Rutkowski S; Gustafsson G; Pietsch T;
    Oncotarget; 2015 Nov; 6(36):38827-39. PubMed ID: 26420814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched.
    Pietsch T; Waha A; Koch A; Kraus J; Albrecht S; Tonn J; Sörensen N; Berthold F; Henk B; Schmandt N; Wolf HK; von Deimling A; Wainwright B; Chenevix-Trench G; Wiestler OD; Wicking C
    Cancer Res; 1997 Jun; 57(11):2085-8. PubMed ID: 9187099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of Chromosome Loss: Why Do Cells Need Each Chromosome Twice?
    Chunduri NK; Barthel K; Storchova Z
    Cells; 2022 May; 11(9):. PubMed ID: 35563836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide characterization of human minisatellite VNTRs: population-specific alleles and gene expression differences.
    Eslami Rasekh M; Hernández Y; Drinan SD; Fuxman Bass JI; Benson G
    Nucleic Acids Res; 2021 May; 49(8):4308-4324. PubMed ID: 33849068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive identification of a two-genesignature as a novel potential prognostic model for patients with medulloblastoma.
    Wang Z; Sun X; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Am J Transl Res; 2020; 12(5):1600-1613. PubMed ID: 32509164
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Daniel SG; Russ AD; Guthridge KM; Raina AI; Estes PS; Parsons LM; Richardson HE; Schroeder JA; Zarnescu DC
    Biol Open; 2018 Jan; 7(1):. PubMed ID: 29361610
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer.
    Putcha BD; Jia X; Katkoori VR; Salih C; Shanmugam C; Jadhav T; Bovell LC; Behring MP; Callens T; Messiaen L; Bae S; Grizzle WE; Singh KP; Manne U
    PLoS One; 2015; 10(6):e0129216. PubMed ID: 26070152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic prognostication within medulloblastoma subgroups.
    Shih DJ; Northcott PA; Remke M; Korshunov A; Ramaswamy V; Kool M; Luu B; Yao Y; Wang X; Dubuc AM; Garzia L; Peacock J; Mack SC; Wu X; Rolider A; Morrissy AS; Cavalli FM; Jones DT; Zitterbart K; Faria CC; Schüller U; Kren L; Kumabe T; Tominaga T; Shin Ra Y; Garami M; Hauser P; Chan JA; Robinson S; Bognár L; Klekner A; Saad AG; Liau LM; Albrecht S; Fontebasso A; Cinalli G; De Antonellis P; Zollo M; Cooper MK; Thompson RC; Bailey S; Lindsey JC; Di Rocco C; Massimi L; Michiels EM; Scherer SW; Phillips JJ; Gupta N; Fan X; Muraszko KM; Vibhakar R; Eberhart CG; Fouladi M; Lach B; Jung S; Wechsler-Reya RJ; Fèvre-Montange M; Jouvet A; Jabado N; Pollack IF; Weiss WA; Lee JY; Cho BK; Kim SK; Wang KC; Leonard JR; Rubin JB; de Torres C; Lavarino C; Mora J; Cho YJ; Tabori U; Olson JM; Gajjar A; Packer RJ; Rutkowski S; Pomeroy SL; French PJ; Kloosterhof NK; Kros JM; Van Meir EG; Clifford SC; Bourdeaut F; Delattre O; Doz FF; Hawkins CE; Malkin D; Grajkowska WA; Perek-Polnik M; Bouffet E; Rutka JT; Pfister SM; Taylor MD
    J Clin Oncol; 2014 Mar; 32(9):886-96. PubMed ID: 24493713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal heterogeneity and instability characterize pediatric medulloblastoma cell lines and affect neoplastic phenotype.
    Castro-Gamero AM; Borges KS; Lira RC; Andrade AF; Fedatto PF; Cruzeiro GA; Silva RB; Fontes AM; Valera ET; Bobola M; Scrideli CA; Tone LG
    Cytotechnology; 2013 Oct; 65(5):871-85. PubMed ID: 23325114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A statin-regulated microRNA represses human c-Myc expression and function.
    Takwi AA; Li Y; Becker Buscaglia LE; Zhang J; Choudhury S; Park AK; Liu M; Young KH; Park WY; Martin RC; Li Y
    EMBO Mol Med; 2012 Sep; 4(9):896-909. PubMed ID: 22887866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.
    Künkele A; De Preter K; Heukamp L; Thor T; Pajtler KW; Hartmann W; Mittelbronn M; Grotzer MA; Deubzer HE; Speleman F; Schramm A; Eggert A; Schulte JH
    Neuro Oncol; 2012 Jul; 14(7):859-69. PubMed ID: 22591662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDM2 promotes WIP1-mediated medulloblastoma growth.
    Buss MC; Read TA; Schniederjan MJ; Gandhi K; Castellino RC
    Neuro Oncol; 2012 Apr; 14(4):440-58. PubMed ID: 22379189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive large cell medulloblastoma extending to the extracranial region in brain-dead state.
    Miwa T; Oi S; Nonaka Y; Tamogami R; Sasaki H; Yoshinari S; Ida H
    Childs Nerv Syst; 2011 Aug; 27(8):1341-6. PubMed ID: 21533576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma.
    McCabe MG; Bäcklund LM; Leong HS; Ichimura K; Collins VP
    Neuro Oncol; 2011 Apr; 13(4):376-83. PubMed ID: 21292688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnostics in embryonal brain tumors.
    Eberhart CG
    Brain Pathol; 2011 Jan; 21(1):96-104. PubMed ID: 21129063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma.
    Briggs KJ; Corcoran-Schwartz IM; Zhang W; Harcke T; Devereux WL; Baylin SB; Eberhart CG; Watkins DN
    Genes Dev; 2008 Mar; 22(6):770-85. PubMed ID: 18347096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.
    Katkoori VR; Jia X; Chatla C; Kumar S; Ponnazhagan S; Callens T; Messiaen L; Grizzle WE; Manne U
    Front Biosci; 2008 Jan; 13():1050-61. PubMed ID: 17981610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D.
    Castellino RC; De Bortoli M; Lu X; Moon SH; Nguyen TA; Shepard MA; Rao PH; Donehower LA; Kim JY
    J Neurooncol; 2008 Feb; 86(3):245-56. PubMed ID: 17932621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.